126 related articles for article (PubMed ID: 32229161)
1. Corrigendum to "Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer" [Canc. Lett. 438 (2018, Dec 1) 165-173].
Lin CC; Lo MC; Moody R; Jiang H; Harouaka R; Stevers N; Tinsley S; Gasparyan M; Wicha M; Sun D
Cancer Lett; 2020 Jun; 480():51. PubMed ID: 32229161
[No Abstract] [Full Text] [Related]
2. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.
Lin CC; Lo MC; Moody R; Jiang H; Harouaka R; Stevers N; Tinsley S; Gasparyan M; Wicha M; Sun D
Cancer Lett; 2018 Dec; 438():165-173. PubMed ID: 30227220
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway" [Canc. Lett. (2023) 216142].
Zhang Y; Chen J; Mi D; Ling J; Li H; He P; Liu N; Chen Q; Chen Y; Huang L
Cancer Lett; 2023 Jul; 567():216195. PubMed ID: 37156646
[No Abstract] [Full Text] [Related]
4. Corrigendum to "Targeting autophagy in cancer stem cells as an anticancer therapy" [Canc. Lett. 393 (2017) 33-39].
Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
Cancer Lett; 2018 Mar; 416():149. PubMed ID: 29307478
[No Abstract] [Full Text] [Related]
5. Corrigendum to "MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer", [Canc. Lett. 399 (2017) 53-63].
Ou C; Sun Z; Li X; Li X; Ren W; Qin Z; Zhang X; Yuan W; Wang J; Yu W; Zhang S; Peng Q; Yan Q; Xiong W; Li G; Ma J
Cancer Lett; 2018 Apr; 420():260. PubMed ID: 29429755
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Long noncoding RNA LINC00657 inhibits cervical cancer development by sponging miR-20a-5p and targeting RUNX3" [Canc. Lett. 498 (2021) 130-141].
Qin X; Zhou M; Lv H; Mao X; Li X; Guo H; Li L; Xing H
Cancer Lett; 2021 Jun; 508():73-75. PubMed ID: 33798906
[No Abstract] [Full Text] [Related]
7. Corrigendum to 'GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft' [Canc. Lett. 330 (2013) 22-32].
Fu J; Rodova M; Roy SK; Sharma J; Singh KP; Srivastava RK; Shankar S
Cancer Lett; 2021 Dec; 522():282. PubMed ID: 34565620
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells" [Canc. Lett. 412 (2018) 297-307].
Le HT; Nguyen HT; Min HY; Hyun SY; Kwon S; Lee Y; Le THV; Lee J; Park JH; Lee HY
Cancer Lett; 2018 Jun; 424():136. PubMed ID: 29573834
[No Abstract] [Full Text] [Related]
9. Corrigendum to " 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling" [Canc. Lett. 471 (2020) 135-146].
Yue Y; Qian W; Li J; Wu S; Zhang M; Wu Z; Ma Q; Wang Z
Cancer Lett; 2022 Nov; 549():215913. PubMed ID: 36152564
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B" [Canc. Lett. 535 (2022) 215629].
Liu Y; Zhang Z; Gao X; Ma Q; Yu Z; Huang S
Cancer Lett; 2022 Jul; 539():215701. PubMed ID: 35527117
[No Abstract] [Full Text] [Related]
11. Corrigendum to "SUMOylation of SYNJ2BP-COX16 promotes breast cancer progression through DRP1-mediated mitochondrial fission" [Canc. Lett. 547 (2022) 215871].
Wang M; Wei R; Li G; Bi HL; Jia Z; Zhang M; Pang M; Li X; Ma L; Tang Y
Cancer Lett; 2022 Nov; 549():215923. PubMed ID: 36166936
[No Abstract] [Full Text] [Related]
12. Corrigendum to "cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells" [Canc. Lett. 403 (2017) 260-270].
Fu H; He Y; Qi L; Chen L; Luo Y; Chen L; Li Y; Zhang N; Guo H
Cancer Lett; 2021 Feb; 498():240-241. PubMed ID: 33221059
[No Abstract] [Full Text] [Related]
13. Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Canc. Lett. 410 (2017) 68-81].
Fu Z; Chen C; Zhou Q; Wang Y; Zhao Y; Zhao X; Li W; Zheng S; Ye H; Wang L; He Z; Lin Q; Li Z; Chen R
Cancer Lett; 2022 Oct; 545():215836. PubMed ID: 35934602
[No Abstract] [Full Text] [Related]
14. Corrigendum to "Glioblastoma extracellular vesicles induce the tumour-promoting transformation of neural stem cells" [Canc. Lett. 466 (2019) 1-12].
Wang J; Liu J; Sun G; Meng H; Wang J; Guan Y; Yin Y; Zhao Z; Dong X; Yin S; Li H; Cheng Y; Wu H; Wu A; Yu X; Chen L
Cancer Lett; 2021 Feb; 498():245-246. PubMed ID: 33342533
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer" [Canc. Lett. 459 (2019 Sep 10) 122-134].
Liu X; Lu Y; Xu Y; Hou S; Huang J; Wang B; Zhao J; Xia S; Fan S; Yu X; Du Y; Hou L; Li Z; Ding Z; An S; Huang B; Li L; Tang J; Ju J; Guan H; Song B
Cancer Lett; 2022 Jul; 539():215695. PubMed ID: 35501203
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer" [Canc. Lett. 459(2019)204-215].
Zhang B; Ye H; Ren X; Zheng S; Zhou Q; Chen C; Lin Q; Li G; Wei L; Fu Z; Zhang Y; Hu C; Li Z; Chen R
Cancer Lett; 2022 Nov; 548():215897. PubMed ID: 36050250
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway" [Canc. Lett. (2009) 282(2) 167-76 doi:10.1016/j.canlet.2009.03.003].
Bhui K; Prasad S; George J; Shukla Y
Cancer Lett; 2020 Jun; 480():48. PubMed ID: 32035655
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway" [Canc. Lett. 342 (2014) 150-158].
Zhao Z; Wu MS; Zou C; Tang Q; Lu J; Liu D; Wu Y; Yin J; Xie X; Shen J; Kang T; Wang J
Cancer Lett; 2021 Dec; 522():281. PubMed ID: 34561145
[No Abstract] [Full Text] [Related]
19. Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36-46].
Lu T; Li Z; Yang Y; Ji W; Yu Y; Niu X; Zeng Q; Xia W; Lu S
Cancer Lett; 2018 Sep; 431():244. PubMed ID: 29754994
[No Abstract] [Full Text] [Related]
20. Corrigendum to "TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer" [Canc. Lett. 412 (2018) 155-169].
Bogusławska J; Rodzik K; Popławski P; Kędzierska H; Rybicka B; Sokół E; Tański Z; Piekiełko-Witkowska A
Cancer Lett; 2020 Jun; 480():52-55. PubMed ID: 32005526
[No Abstract] [Full Text] [Related]
[Next] [New Search]